Lv2
128 积分 2024-05-27 加入
The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
22天前
已完结
Atherosclerosis and Non-Alcoholic Fatty Liver Disease
22天前
已完结
Glycemic Control Is Associated with the Histological Severity of Nonalcoholic Fatty Liver Disease
1个月前
已完结
Lean nonalcoholic fatty liver disease and sarcopenia
1个月前
已完结
Lipid accumulation product is a valid predictor of hepatic steatosis and nonalcoholic fatty liver disease
1个月前
已完结
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Patients—The Relationship with Platelets Indicators
1个月前
已完结
The systemic immune inflammation index is a reliable and novel risk factor for metabolic dysfunction-associated fatty liver disease
1个月前
已完结
Monocytes to Apolipoprotein A1 ratio is associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus
1个月前
已完结
Association between triglyceride-glucose related indices and severe infection requiring hospital admission or resulting in mortality among individuals with metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Fatty Liver Index vs. Biochemical–Anthropometric Indices: Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease with Non-Invasive Tools
1个月前
已完结
皖公网安备34019202002308
